VAERS Explorer
Back to explore

Report #2839762

Received May 6, 2025

ER / ED visit
A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex
Male
Age
Age unknown
State
—
Recovered
Not recovered
Vaccinated
Apr 29, 2025
Onset
May 1, 2025
Days to onset
2
Hospital days
—

Vaccines (1)

TypeNameManufacturerDoseLotRoute / Site
VARZOSZOSTER (SHINGRIX)GLAXOSMITHKLINE BIOLOGICALSUNKUNK—

Symptoms (2)

RashUrticaria

Symptom narrative

rash; Hives; This non-serious case was reported by a consumer and described the occurrence of rash in a 65-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis. Concurrent medical conditions included acne rosacea. Concomitant products included doxycycline. On 29-APR-2025, the patient received Shingrix. On 01-MAY-2025, 2 days after receiving Shingrix, the patient experienced rash (Verbatim: rash) and hives (Verbatim: Hives). The outcome of the rash and hives were not resolved. It was unknown if the reporter considered the rash and hives to be related to Shingrix. It was unknown if the company considered the rash and hives to be related to Shingrix. Additional Information: GSK Receipt Date: 01-MAY-2025 The patient self reported this case for himself.

Current illness

Acne rosacea

Other medications

Doxycycline